Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


04.02.2019

1 Am J Nurs
1 Asian Pac J Cancer Prev
1 Bioorg Chem
1 BMC Cancer
1 BMC Res Notes
1 BMC Womens Health
1 BMJ Open
1 Cancer Manag Res
1 Cancer Res
1 Clin Imaging
1 Eur J Cancer
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Pharm Sci
1 Eur J Pharmacol
1 Eur J Surg Oncol
1 Exp Cell Res
1 Front Oncol
1 HIV Med
1 Hum Cell
1 Hum Immunol
1 Indian J Cancer
1 Indian J Community Med
2 Int J Gynaecol Obstet
2 Int J Mol Sci
1 Int J Oncol
1 J Cell Biochem
1 J Cell Mol Med
1 J Clin Med
1 J Glob Oncol
1 J Int Med Res
1 J Midlife Health
1 J Pediatr Adolesc Gynecol
1 JMIR Form Res
1 Medicine (Baltimore)
1 Mol Cell Proteomics
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Neoplasia
1 Obstet Gynecol Clin North Am
1 Oncogene
1 Oncol Rep
1 Oncotarget
2 PLoS One
5 Salud Publica Mex
1 Stem Cells Dev
1 Strahlenther Onkol
1 Virchows Arch
1 Womens Health (Lond)
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Nurs


  1. NewsCAP: Studies question the minimally invasive approach for treating cervical cancer.
    Am J Nurs. 2019;119:14.
    PubMed     Text format    


    Asian Pac J Cancer Prev

  2. FUJIWARA H, Suzuki M, Morisawa H, Sayama M, et al
    The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan
    Asian Pac J Cancer Prev. 2019;20:81-85.
    PubMed     Text format     Abstract available


    Bioorg Chem

  3. ABD EL-KARIM SS, Syam YM, El Kerdawy AM, Abdelghany TM, et al
    New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
    Bioorg Chem. 2019;86:80-96.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. VAN DE SANDE AJM, Koeneman MM, Gerestein CG, Kruse AJ, et al
    TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
    BMC Cancer. 2018;18:655.
    PubMed     Text format     Abstract available


    BMC Res Notes

  5. TAREKEGN AA, Yismaw AE
    Health professionals' willingness to pay and associated factors for human papilloma virus vaccination to prevent cervical cancer at College of Medicine and Health Sciences University of Gondar, Northwest Ethiopia.
    BMC Res Notes. 2019;12:58.
    PubMed     Text format     Abstract available


    BMC Womens Health

  6. KRINGS A, Duckelmann AM, Moser L, Gollrad J, et al
    Performance of OncoE6 cervical test with collection methods enabling self-sampling.
    BMC Womens Health. 2018;18:68.
    PubMed     Text format     Abstract available


    BMJ Open

  7. PESOLA F, Sasieni P
    Impact of screening on cervical cancer incidence in England: a time trend analysis.
    BMJ Open. 2019;9:e026292.
    PubMed     Text format     Abstract available


    Cancer Manag Res


  8. Erratum: Securidaca-saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum].
    Cancer Manag Res. 2019;11:691.
    PubMed     Text format     Abstract available


    Cancer Res

  9. WALCH-RUCKHEIM B, Stroder R, Theobald L, Pahne-Zeppenfeld J, et al
    Cervical cancer-instructed stromal fibroblasts enhance IL-23 expression in dendritic cells to support expansion of Th17 cells.
    Cancer Res. 2019 Jan 29. pii: 0008-5472.CAN-18-1913.
    PubMed     Text format     Abstract available


    Clin Imaging

  10. ZHAO W, Wang X, Liang Y
    Application of 64-slice MSCT with ovarian vein tracking technique in identification of suture-fixed transposed ovaries.
    Clin Imaging. 2018;52:113-116.
    PubMed     Text format     Abstract available


    Eur J Cancer

  11. HESCOT S, Haissaguerre M, Pautier P, Kuhn E, et al
    Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect.
    Eur J Cancer. 2018;97:57-58.
    PubMed     Text format    


    Eur J Obstet Gynecol Reprod Biol

  12. CIAVATTINI A, Serri M, Di Giuseppe J, Liverani CA, et al
    Reliability of colposcopy during pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2018;229:76-81.
    PubMed     Text format     Abstract available


    Eur J Pharm Sci

  13. VARAN C, Sen M, Sandler N, Aktas Y, et al
    Mechanical characterization and ex vivo evaluation of anticancer and antiviral drug printed bioadhesive film for the treatment of cervical cancer.
    Eur J Pharm Sci. 2019 Jan 25. pii: S0928-0987(19)30044.
    PubMed     Text format     Abstract available


    Eur J Pharmacol

  14. XIA C, He Z, Liang S, Chen R, et al
    Metformin combined with nelfinavir induces SIRT3/mROS - dependent autophagy in human cervical cancer cells and xenograft in nude mice.
    Eur J Pharmacol. 2019 Jan 26. pii: S0014-2999(19)30065.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  15. DE FOUCHER T, Bendifallah S, Ouldamer L, Bricou A, et al
    Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    Eur J Surg Oncol. 2018 Dec 30. pii: S0748-7983(18)32012.
    PubMed     Text format     Abstract available


    Exp Cell Res

  16. LI S, Ren B, Yue S, Gao H, et al
    Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer.
    Exp Cell Res. 2019 Jan 25. pii: S0014-4827(19)30020.
    PubMed     Text format     Abstract available


    Front Oncol

  17. SANTAMARIA-ULLOA C, Valverde-Manzanares C
    Inequality in the Incidence of Cervical Cancer: Costa Rica 1980-2010.
    Front Oncol. 2019;8:664.
    PubMed     Text format     Abstract available


    HIV Med

  18. GRABAR S, Hleyhel M, Belot A, Bouvier AM, et al
    Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS)
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12703.
    PubMed     Text format     Abstract available


    Hum Cell

  19. LI J, Chu ZP, Han H, Zhang Y, et al
    Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
    Hum Cell. 2019 Jan 28. pii: 10.1007/s13577-018-00225.
    PubMed     Text format     Abstract available


    Hum Immunol

  20. ROCA AM, Chobrutskiy BI, Callahan BM, Blanck G, et al
    T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
    Hum Immunol. 2019 Jan 23. pii: S0198-8859(18)31053.
    PubMed     Text format     Abstract available


    Indian J Cancer

  21. SINGH J, Roy B, Yadav A, Siddiqui S, et al
    Cervical cancer awareness and HPV vaccine acceptability among females in Delhi: A cross-sectional study.
    Indian J Cancer. 2018;55:233-237.
    PubMed     Text format     Abstract available


    Indian J Community Med

  22. SWAIN D, Parida SP
    Preparedness of Young Girls for Prevention of Cervical Cancer and Strategy to introduce the HPV Vaccine.
    Indian J Community Med. 2018;43.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  23. CAMPOS NG, Maza M, Alfaro K, Gage JC, et al
    The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Int J Gynaecol Obstet. 2019 Jan 31. doi: 10.1002/ijgo.12773.
    PubMed     Text format     Abstract available

  24. RISLEY C, Geisinger KR, Robinson JC, Stewart MW, et al
    Precancerous cervical lesions and HPV genotypes identified in previously unsatisfactory cervical smear tests after inexpensive glacial acetic acid processing.
    Int J Gynaecol Obstet. 2018 Oct 26. doi: 10.1002/ijgo.12699.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  25. MUNOZ-BELLO JO, Olmedo-Nieva L, Castro-Munoz LJ, Manzo-Merino J, et al
    HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/beta-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available

  26. CORDOVA-RIVAS S, Fraire-Soto I, Mercado-Casas Torres A, Servin-Gonzalez LS, et al
    5p and 3p Strands of miR-34 Family Members Have Differential Effects in Cell Proliferation, Migration, and Invasion in Cervical Cancer Cells.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available


    Int J Oncol

  27. LIU J, Zhen YZ, Cui J, Hu G, et al
    Dynamic influence of Rhein lysinate on HeLa cells.
    Int J Oncol. 2018;53:2047-2055.
    PubMed     Text format     Abstract available


    J Cell Biochem

  28. FU Y, Meng Y, Gu X, Tian S, et al
    miR-503 expression is downregulated in cervical cancer and suppresses tumor growth by targeting AKT2.
    J Cell Biochem. 2019 Jan 29. doi: 10.1002/jcb.28099.
    PubMed     Text format     Abstract available


    J Cell Mol Med

  29. YAN SP, Chu DX, Qiu HF, Xie Y, et al
    LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    J Cell Mol Med. 2019 Jan 29. doi: 10.1111/jcmm.14161.
    PubMed     Text format     Abstract available


    J Clin Med

  30. KONES R, Rumana U, Arain F
    A General Pathway Model for Improving Health Disparities: Lessons from Community and Cultural Involvement in Improving Cervical Cancer Screening in Vietnamese Women.
    J Clin Med. 2019;8.
    PubMed     Text format     Abstract available


    J Glob Oncol

  31. FERREIRA DA SILVA I, Ferreira da Silva I, Koifman RJ
    Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country.
    J Glob Oncol. 2019;:1-11.
    PubMed     Text format     Abstract available


    J Int Med Res

  32. SHANSHAN H, Lan X, Xia L, Huang W, et al
    Inhibition of protease-activated receptor-2 induces apoptosis in cervical cancer by inhibiting signal transducer and activator of transcription-3 signaling.
    J Int Med Res. 2019 Jan 30:300060518820440. doi: 10.1177/0300060518820440.
    PubMed     Text format     Abstract available


    J Midlife Health

  33. JHAMAD S, Aanjane R, Jaiswal S, Jain S, et al
    Second Primary Cancer after Radiotherapy for Cervical Cancer.
    J Midlife Health. 2018;9:207-209.
    PubMed     Text format     Abstract available


    J Pediatr Adolesc Gynecol

  34. GANTI AK, Ray J, Mooney KL, Zambrano E, et al
    Unusual Cause of Pediatric Vaginal Bleeding: Infantile Capillary Hemangioma of the Cervix.
    J Pediatr Adolesc Gynecol. 2019;32:80-82.
    PubMed     Text format     Abstract available


    JMIR Form Res

  35. LE D, Aldoory L, Garza MA, Fryer CS, et al
    A Spiritually-Based Text Messaging Program to Increase Cervical Cancer Awareness Among African American Women: Design and Development of the CervixCheck Pilot Study.
    JMIR Form Res. 2018;2:e5.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  36. ZHANG SS, Ding T, Cui ZH, Lv Y, et al
    Efficacy of robotic radical hysterectomy for cervical cancer compared with that of open and laparoscopic surgery: A separate meta-analysis of high-quality studies.
    Medicine (Baltimore). 2019;98:e14171.
    PubMed     Text format     Abstract available


    Mol Cell Proteomics

  37. BERGGRUND M, Enroth S, Lundberg M, Assarsson E, et al
    Identification of candidate plasma protein biomarkers for cervical cancer using the multiplex proximity extension assay.
    Mol Cell Proteomics. 2019 Jan 28. pii: RA118.001208.
    PubMed     Text format     Abstract available


    Nan Fang Yi Ke Da Xue Xue Bao

  38. QIU F, Chen F, Liu D, Xu J, et al
    [LC-MS/MS-based screening of new protein biomarkers for cervical precancerous lesions and cervical cancer].
    Nan Fang Yi Ke Da Xue Xue Bao. 2019;39:13-22.
    PubMed     Text format     Abstract available


    Neoplasia

  39. AKIMOTO T, Takasawa A, Takasawa K, Aoyama T, et al
    Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.
    Neoplasia. 2018;20:1083-1093.
    PubMed     Text format     Abstract available


    Obstet Gynecol Clin North Am

  40. CASTLE PE, Pierz A
    (At Least) Once in Her Lifetime: Global Cervical Cancer Prevention.
    Obstet Gynecol Clin North Am. 2019;46:107-123.
    PubMed     Text format     Abstract available


    Oncogene

  41. DONG P, Xiong Y, Yu J, Chen L, et al
    Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer.
    Oncogene. 2019 Jan 24. pii: 10.1038/s41388-019-0677.
    PubMed     Text format     Abstract available


    Oncol Rep

  42. SU X, Zhang L, Kang H, Zhang B, et al
    Mechanical, nanomorphological and biological reconstruction of earlystage apoptosis in HeLa cells induced by cytochalasin B.
    Oncol Rep. 2019;41:928-938.
    PubMed     Text format     Abstract available


    Oncotarget

  43. TANAKA T, Terai Y, Fujiwara S, Tanaka Y, et al
    Neoadjuvant intra-arterial chemotherapy using an original four-lumen double-balloon catheter for locally advanced uterine cervical cancer.
    Oncotarget. 2018;9:37766-37776.
    PubMed     Text format     Abstract available


    PLoS One

  44. BASTA T, Knapp P, Blecharz P, Bodnar L, et al
    Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations.
    PLoS One. 2019;14:e0209901.
    PubMed     Text format     Abstract available

  45. TORRES KL, Marino JM, Pires Rocha DA, de Mello MB, et al
    Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas.
    PLoS One. 2018;13:e0201262.
    PubMed     Text format     Abstract available


    Salud Publica Mex

  46. BOSCH FX, Robles C
    HPV-FASTER: Combined strategies of HPV vaccination and HPV screening towards a one visit for cervical cancer preventive campaigns.
    Salud Publica Mex. 2018;60:612-616.
    PubMed     Text format    

  47. HURTADO-SALGADO E, Ortiz-Panozo E, Salmeron J, Saavedra-Lara N, et al
    Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study.
    Salud Publica Mex. 2018;60:722-733.
    PubMed     Text format     Abstract available

  48. FERRECCIO C
    [New strategies for the prevention and control of cervical cancer in Chile.]
    Salud Publica Mex. 2018;60:713-721.
    PubMed     Text format     Abstract available

  49. HERRERO R
    [Elimination of cervical cancer in Latin America].
    Salud Publica Mex. 2018;60:621-623.
    PubMed     Text format    

  50. FRANCO EL
    Prevention of cervical cancer in Latin America: Future challenges and opportunities.
    Salud Publica Mex. 2018;60:609-611.
    PubMed     Text format    


    Stem Cells Dev

  51. AVILA-IBARRA LR, Mora-Garcia ML, Garcia-Rocha R, Hernandez-Montes J, et al
    Mesenchymal stromal cells derived from normal cervix and cervical cancer tumors increase CD73 expression in cervical cancer cells through TGF-beta1 production.
    Stem Cells Dev. 2019 Jan 30. doi: 10.1089/scd.2018.0183.
    PubMed     Text format     Abstract available


    Strahlenther Onkol

  52. SAUER G, Kurzeder C, Schneider A
    [Impact of surgical approach on prognosis in early-stage cervical cancer].
    Strahlenther Onkol. 2019 Jan 28. pii: 10.1007/s00066-019-01426.
    PubMed     Text format    


    Virchows Arch

  53. ASAKA S, Nakajima T, Momose M, Miyamoto T, et al
    Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Virchows Arch. 2019;474:79-86.
    PubMed     Text format     Abstract available


    Womens Health (Lond)

  54. AKAABOUNE M, Kenfack B, Viviano M, Temogne L, et al
    Clearance and persistence of the human papillomavirus infection among Cameroonian women.
    Womens Health (Lond). 2018;14:1745506518805642.
    PubMed     Text format     Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  55. SHEN DH
    [Pathologists is indispensable, in screening, diagnosis and therapy of uterine cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:3-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: